Please assess the completion status of the following clinical trial:

Trial Title: Linking Infectious and Narcology Care-Part II

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years or older~* HIV infected~* Hospitalized at narcology hospital~* History of injection drug use~* Current diagnosis of opioid use disorder~* Provision of information for 2 contacts to assist with follow-up~* Address within 100 kilometers of St. Petersburg~* Possession of a telephone (home or cell)~* Able and willing to comply with all study protocols and procedures~Exclusion Criteria:~* Not fluent in Russian~* Cognitive impairment~* Pregnancy, planning to become pregnant, or breastfeeding~* ART use in past 30 days prior to hospitalization~* Known hypersensitivity to naltrexone~* Acute severe psychiatric illness (i.e. ,answered yes to any of the following: past three month active hallucinations; mental health symptoms prompting a visit to the ED or hospital; mental health medication changes due to worsening symptoms; presence of suicidal ideations)~* Known history of liver failure~* ALT or AST \>5 times the upper limit of normal~* Known severe thrombocytopenia (\<50k)~* Known coagulation disorder/taking anticoagulation medications~* Body habitus that precludes intramuscular injection~* Known hypersensitivity to naloxone~* Known history of Raynaud's disease~* Known history of Itsenko-Cushing syndrome~* Known history of generalized mycoses~* Known history of glaucoma~* Known history of osteoporosis.~* Planned surgeries in the next 12 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- LINC-II (Type: EXPERIMENTAL): LINC-II is a multi-faceted intervention combining pharmacological therapy (i.e., ART and naltrexone for opioid use disorder) and 12 months of strengths-based case management delivered to coordinate care across the narcology and HIV health care systems.
- Standard of Care (Type: NO_INTERVENTION): Participants randomized to the control group will receive the narcology hospital's standard of care, which is detoxification with or without stabilization. Prior to discharge, those identified as HIV-infected are given contact details for an HIV clinic, not an appointment. Upon discharge, patients are encouraged to receive outpatient narcology treatment, monthly, for 1 year. For this study, with regard to linkage to HIV medical care, patients will be given printed information about where to obtain HIV medical care and a resource card containing harm reduction information.

Based on this trial design, predict the completion outcome and termination type (if applicable).